Veradermics reports Q3 2026 results, $798.4 million cash, runway into 2030Nov 10Clinical readoutAbsci CorpVDPHL01Updated
Absci reports Q2 2026 results, positive ABS-201 Phase 1 data, $100M raise with LillyAug 11Quarterly updateAbsci CorpEli Lilly